Neurology & Neurotherapeutics

Medicine & Life Sciences

1. Alzheimer Disease 58%
2. Amyloid 17%
3. Antibodies 20%
4. Apolipoproteins E 14%
5. Arterial Pressure 14%
6. B-Lymphocytes 11%
7. Biomarkers 16%
8. Blood Flow Velocity 11%
9. Blood Pressure 16%
10. Blood Vessels 11%
11. Brain 70%
12. Brain Injuries 13%
13. Brain Neoplasms 11%
14. Central Nervous System 19%
15. Cerebral Hemorrhage 15%
16. Cerebrospinal Fluid 16%
17. Cerebrovascular Circulation 28%
18. Child 21%
19. Cholinergic Receptors 11%
20. Clinical Trials 17%
21. Cognition 17%
22. Cognitive Dysfunction 35%
23. Cyclin-Dependent Kinase 5 16%
24. Dementia 20%
25. Depression 21%
26. Duchenne Muscular Dystrophy 11%
27. Electroconvulsive Therapy 19%
28. Electroencephalography 20%
29. Epilepsy 30%
30. Essential Tremor 19%
31. Exercise 22%
32. Eye 14%
33. Genes 30%
34. Glioblastoma 20%
35. Glioma 16%
36. Glucose 12%
37. Glycogen Storage Disease Type V 17%
38. Guidelines 15%
39. Headache 14%
40. Hippocampus 11%
41. Homeostasis 16%
42. Intracranial Pressure 12%
43. LDL Receptors 27%
44. LDL-Receptor Related Proteins 15%
45. Lipoprotein Receptors 23%
46. low density lipoprotein receptor-related protein 8 14%
47. Low Density Lipoprotein Receptor-Related Protein-1 23%
48. Magnetic Resonance Imaging 30%
49. Magnetic Resonance Spectroscopy 13%
50. Major Depressive Disorder 12%
51. Membranes 17%
52. Memory 30%
53. Mental Status and Dementia Tests 12%
54. Migraine Disorders 15%
55. Multiple Sclerosis 98%
56. Muscles 30%
57. Muscular Diseases 11%
58. Mutation 38%
59. Myasthenia Gravis 12%
60. Natalizumab 12%
61. Neoplasms 15%
62. Nerve Fibers 13%
63. Nervous System 17%
64. Nervous System Diseases 14%
65. Neurodegenerative Diseases 13%
66. Neuroimaging 13%
67. Neurology 17%
68. Neuromyelitis Optica 15%
69. Neurons 24%
70. Optical Coherence Tomography 12%
71. Parkinson Disease 24%
72. Pathology 13%
73. Pediatrics 20%
74. Pharmaceutical Preparations 11%
75. Phenotype 18%
76. Phosphorylation 11%
77. Placebos 19%
78. Population 15%
79. Proteins 27%
80. Pseudotumor Cerebri 14%
81. Quality of Life 11%
82. Randomized Controlled Trials 14%
83. Registries 15%
84. Safety 19%
85. Seizures 39%
86. Semantics 13%
87. Skeletal Muscle 20%
88. Sodium Channels 11%
89. Spinal Muscular Atrophy 20%
90. Stress Urinary Incontinence 12%
91. Stroke 100%
92. Subarachnoid Hemorrhage 15%
93. T-Lymphocytes 11%
94. Therapeutics 48%
95. Tissue Plasminogen Activator 15%
96. Traumatic Brain Injury 18%
97. Tuberous Sclerosis 14%
98. Urodynamics 15%
99. White Matter 16%
100. Wounds and Injuries 19%